Akifumi Kiyota
Kumamoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
IL-6 Levels Correlate with Prognosis and Immunosuppressive Stromal Cells in Patients with Colorectal Cancer.
Journal: Annals of surgical oncology
Published: August 05, 2022
An epithelial cell adhesion molecule- and CD3-bispecific antibody plus activated T-cells can eradicate chemoresistant cancer stem-like pancreatic carcinoma cells in vitro.
Journal: Anticancer research
Published: July 31, 2014
NKG2D-directed cytokine-activated killer lymphocyte therapy combined with gemcitabine for patients with chemoresistant metastatic solid tumors.
Journal: Anticancer research
Published: July 31, 2014
Random migration contributes to cytotoxicity of activated CD8+ T-lymphocytes but not NK cells.
Journal: Anticancer research
Published: July 31, 2014
The Hedgehog inhibitor suppresses the function of monocyte-derived dendritic cells from patients with advanced cancer under hypoxia.
Journal: Biochemical and biophysical research communications
Published: May 08, 2013
Combining celecoxib with sorafenib synergistically inhibits hepatocellular carcinoma cells in vitro.
Combining celecoxib with sorafenib synergistically inhibits hepatocellular carcinoma cells in vitro.
Journal: Anticancer research
Published: April 09, 2013
The Hedgehog inhibitor cyclopamine impairs the benefits of immunotherapy with activated T and NK lymphocytes derived from patients with advanced cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: January 21, 2013
A new method for rapid cytotoxic T-lymphocyte induction using a multiple cytokine cocktail.
Journal: Anticancer research
Published: May 30, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026